Study title:
AN 1988147856 19880101.
TI Evaluation of the efficacy and tolerability of an association of cyproheptadine, carnitine and pantethine in the treatment of anorexia in children. Double blind clinical trial vs. cyproheptadine.
AU Berni-Canani-M, Berni-Canani-R.
IN 1 Divisione di Medicina Pediatrica, U.S.L. 40 della Regione Campania, Presidio Regionale Pediatrico, Santobono, Italy.
SO Acta Toxicologica et Therapeutica {ACTA-TOXICOL-THER}, 1988, Vol/Iss /Pg. 9/1 (81-100), ISSN: 0393-635X. YR 1988.AN 1988147856 19880101.
TI Evaluation of the efficacy and tolerability of an association of cyproheptadine, carnitine and pantethine in the treatment of anorexia in children. Double blind clinical trial vs. cyproheptadine.
AU Berni-Canani-M, Berni-Canani-R.
IN 1 Divisione di...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|